See more : Visa Inc. (VISA.NE) Income Statement Analysis – Financial Results
Complete financial analysis of Spineway SA (ALSPW.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spineway SA, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Sutro Biopharma, Inc. (STRO) Income Statement Analysis – Financial Results
- Cullinan Oncology, Inc. (CGEM) Income Statement Analysis – Financial Results
- HELMA Eigenheimbau Aktiengesellschaft (H5E.DE) Income Statement Analysis – Financial Results
- Profit Planners Management, Inc. (PPMT) Income Statement Analysis – Financial Results
- BANIJAY GROUP N.V. (BNJ.AS) Income Statement Analysis – Financial Results
Spineway SA (ALSPW.PA)
About Spineway SA
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; kili, an anterior lumbar interbody fusion cage; twin peaks plif bullet shaped posterior lumbar interbody fusion cages; twin peaks olif graft vascularization interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides sonora, a biomaterial for bone regeneration. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.52M | 7.43M | 4.29M | 3.38M | 5.59M | 6.91M | 9.59M | 5.09M | 5.70M | 5.22M | 6.64M | 4.72M | 3.60M |
| Cost of Revenue | 8.89M | 7.20M | 5.74M | 5.50M | 3.69M | 5.03M | 5.86M | 3.94M | 4.12M | 3.89M | 4.38M | 3.71M | 2.33M |
| Gross Profit | 1.63M | 237.00K | -1.45M | -2.12M | 1.90M | 1.88M | 3.72M | 1.15M | 1.58M | 1.33M | 2.27M | 1.01M | 1.27M |
| Gross Profit Ratio | 15.45% | 3.19% | -33.71% | -62.65% | 33.92% | 27.17% | 38.84% | 22.58% | 27.74% | 25.45% | 34.11% | 21.39% | 35.38% |
| Research & Development | 0.00 | 938.19M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.70M | 1.70M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.80M | 2.09M | 2.08M | 0.00 | 0.00 | 2.37M | 2.23M | 2.07M | 1.97M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -1.76M | -1.93M | 443.57K | 0.00 | 0.00 | -57.36K | 327.07K | 310.91K | -5.63K | 0.00 | 0.00 |
| SG&A | 311.00K | 3.77M | 47.00K | 165.00K | 2.52M | 3.61M | 3.51M | 2.32M | 2.56M | 2.38M | 1.96M | 0.00 | 0.00 |
| Other Expenses | 5.76M | 427.00K | 284.00K | 806.00K | 908.00K | -440.00K | -256.00K | -98.47K | 0.00 | 0.00 | 0.00 | 878.09K | 1.21M |
| Operating Expenses | 6.07M | 3.77M | -237.00K | -641.00K | 4.72M | 5.96M | 4.60M | 3.75M | 3.73M | 3.43M | 2.64M | 878.09K | 1.21M |
| Cost & Expenses | 15.04M | 10.97M | 5.50M | 4.86M | 8.41M | 10.99M | 10.46M | 7.69M | 7.85M | 7.32M | 7.01M | 4.59M | 3.53M |
| Interest Income | 999.00 | 184.00K | 49.00K | 50.00K | 52.00K | 43.00K | 90.00K | 91.00K | 83.71K | 61.88K | 13.55K | 3.00K | 0.00 |
| Interest Expense | 1.03M | 14.00K | 58.00K | 12.32M | 194.00K | 737.00K | 124.00K | 100.45K | 93.03K | 330.44K | 39.21K | 63.27K | 47.49K |
| Depreciation & Amortization | 859.00K | 565.00K | 490.00K | 646.00K | 810.00K | 737.00K | 768.00K | 980.92K | 815.51K | 570.65K | 459.00K | 330.02K | 311.86K |
| EBITDA | -4.79M | -2.76M | -719.00K | -1.32M | -1.55M | -3.17M | -102.00K | -1.48M | -1.33M | -1.26M | 200.06K | 533.69K | 379.67K |
| EBITDA Ratio | -45.55% | -40.20% | -16.76% | -24.56% | -27.69% | -45.84% | -1.06% | -29.11% | -18.07% | -22.99% | 2.63% | 9.85% | 10.55% |
| Operating Income | -4.52M | -3.53M | -1.21M | -1.48M | -2.33M | -3.88M | -845.00K | -2.26M | -1.84M | -1.77M | -284.60K | 132.39K | 67.81K |
| Operating Income Ratio | -42.94% | -47.54% | -28.18% | -43.68% | -41.62% | -56.11% | -8.81% | -44.31% | -32.39% | -33.92% | -4.28% | 2.80% | 1.88% |
| Total Other Income/Expenses | -1.99M | 395.00K | -547.00K | -12.53M | -1.16M | -1.48M | -120.00K | -322.44K | -391.32K | -391.49K | -13.55K | -60.27K | -47.49K |
| Income Before Tax | -6.51M | -3.14M | -1.76M | -14.28M | -2.88M | -4.12M | -965.00K | -2.69M | -2.24M | -2.16M | -384.58K | 72.12K | 20.32K |
| Income Before Tax Ratio | -61.89% | -42.21% | -40.93% | -422.61% | -51.49% | -59.67% | -10.07% | -52.81% | -39.26% | -41.42% | -5.79% | 1.53% | 0.56% |
| Income Tax Expense | -1.00K | 3.34M | -173.00K | -231.00K | -210.00K | -396.00K | -448.00K | -451.06K | 550.77K | 495.91K | 333.17K | -269.49K | -235.40K |
| Net Income | -6.51M | -3.14M | -1.58M | -14.05M | -2.88M | -4.12M | -965.00K | -2.69M | -1.69M | -1.67M | -51.41K | 409.88K | 238.61K |
| Net Income Ratio | -61.89% | -42.21% | -36.90% | -415.77% | -51.49% | -59.67% | -10.07% | -52.81% | -29.59% | -31.92% | -0.77% | 8.68% | 6.63% |
| EPS | -0.41 | -5.48 | -9.53K | -383.88K | -5.13M | -53.44M | -19.95M | -55.69M | -19.15K | -18.94K | -612.05 | 4.88K | 2.84K |
| EPS Diluted | -0.41 | -5.48 | -9.53K | -383.88K | -5.13M | -53.44M | -19.95M | -55.69M | -19.15K | -18.94K | -612.05 | 4.88K | 2.84K |
| Weighted Avg Shares Out | 15.94M | 572.58K | 166.16 | 36.60 | 0.56 | 0.08 | 0.05 | 0.05 | 88.00 | 88.00 | 84.00 | 84.00 | 84.00 |
| Weighted Avg Shares Out (Dil) | 15.94M | 572.58K | 166.16 | 36.60 | 0.56 | 0.08 | 0.05 | 0.05 | 88.00 | 88.00 | 84.00 | 84.00 | 84.00 |
Source: https://incomestatements.info
Category: Stock Reports